GN ought to consider selling off or seperating from its hearing aid division, GN Hearing, to instead focus on the fast-growing headset manufacturer, GN Audio, Nordea writes in an analysis for the bank's clients on Wednesday.
The Danish bank eyes the possibility of a merger of GN and Australian Cochlear, which – as the name implies – manufactures and sells cochlear implants. These hearing devices are surgically implanted in the inner ear, often in children with hearing loss or congenitally deaf children.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.